Anti-F2RL3 Antibody (A334539)

Enlarge Image

This product is discontinued

Anti-F2RL3 Antibody (A334539) has been discontinued and is no longer available.

View all F2RL3 Antibodies.

Specifications

Name

Anti-F2RL3 Antibody

Description

Rabbit polyclonal antibody to F2RL3.

Specificity

This antibody targets the C-terminal region of human F2RL3, recognizing the non-phosphorylated isoform. It is optimized for Western blot analysis, supports immunoprecipitation from cell and tissue lysates, and is suitable for immunohistochemistry in cultured cells and tissue sections.

Applications

WB, IHC

Dilutions

WB: 1,000, IHC: 1:100

Reactivity

Human

Immunogen

Synthetic peptide corresponding to the C-terminal of human F2RL3. Immunogen range is 22-22 amino acids.

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Antigen affinity purification.

Concentration

Lot Specific

Product Form

Liquid

Formulation

Supplied in Dulbecco's PBS, pH 7.4, with 150 mM NaCl and 0.005% Sodium Azide.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.

Synonyms

Coagulation factor II receptor-like 3, PAR-4, PAR4, Proteinase-activated receptor 4, Thrombin receptor-like 3

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (2)

Enlarge Image

Anti-F2RL3 Antibody (A334539)

Western blot validation of F2RL3 in transfected HEK293 cells. Lysates from native HEK293 cells (MOCK) or cells stably expressing F2RL3 were probed with anti-F2RL3 antibody (A334539) at 1:1000.

Enlarge Image

Immunohistochemistry - Anti-F2RL3 Antibody (A334539)

Immunohistochemical detection of F2RL3 in human small intestine. Small intestine sections were dewaxed, microwaved in citric acid, and incubated with anti-F2RL3 antibody (A334539) at 1:100, followed by biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were developed with 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.